(Q34123900)

English

Depressive breakthrough.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11147244%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

Depressive breakthrough (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11147244%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Jonathan E. Alpert

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11147244%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

A A Nierenberg

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11147244%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 December 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11147244%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Psychiatric Clinics of North America

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11147244%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11147244%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

731-742

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11147244%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11147244%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance to therapeutic effects of antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sertraline in the prevention of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year maintenance treatment with citalopram, 20 mg, in unipolar subjects with high recurrence rate

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-year outcomes for maintenance therapies in recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Methodologic issues in maintenance therapy clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term Outcome of Episodes of Major Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-year outcome for maintenance therapies in recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidepressant tachyphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Refractory depression: the addition of lithium to fluoxetine or desipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The prophylactic efficacy of tricyclic antidepressants--a five year followup

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Possible synergism between fluoxetine and lithium in refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of drug effects during continuation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission and relapse in major depression: a two-year prospective follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychiatrists' responses to failure of maintenance therapy with antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of high-dose tricyclic antidepressant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Two dosages of imipramine in hospitalized endogenous and neurotic depressives

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970194-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0193-953X(05)70194-5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11147244%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11147244%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34123900&oldid=1909393202"